T cell-based strategies for HIV-1 vaccines
Despite 30 years of effort, we do not have an effective HIV-1 vaccine. Over the past decade, the HIV-1 vaccine field has shifted emphasis toward antibody-based vaccine strategies, following a lack of efficacy in CD8+ T-cell-based vaccine trials. Several lines of evidence, however, suggest that impro...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Taylor & Francis Group
2020-03-01
|
| Schriftenreihe: | Human Vaccines & Immunotherapeutics |
| Schlagworte: | |
| Online-Zugang: | http://dx.doi.org/10.1080/21645515.2019.1666957 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|